Atlas Trials

Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin in Patients With Advanced Gastric Cancer

Clinical trial NCT02322593 · COMPLETED

Trial details

NCT number
NCT02322593
Sponsor
Taiho Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2014-12-01
Primary completion
2019-02-01
Enrollment
711

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.